vimarsana.com

Latest Breaking News On - Johanna bennett ingrid mezo - Page 1 : vimarsana.com

Mirimus, Inc Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications

Mirimus, Inc Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

AzurRx BioPharma to Present at the Emerging Growth Conference (May 12)

AzurRx BioPharma to Present at the Emerging Growth Conference (May 12) DELRAY BEACH, Fla., May 11, 2021 (GLOBE NEWSWIRE) AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that the Company will make a virtual presentation at the Emerging Growth Conference taking place on Wednesday, May 12th, 2021. During their live virtual presentation at 10:30 a.m. EDT, members of AzurRx’s management team will provide an overview of AzurRx’s business and clinical development programs and discuss anticipated 2021 and early 2022 milestones. Details of the presentation are as follows:

Codagenix Appoints Johanna Kaufmann, Ph D , Executive Vice President, Oncology to Lead Customization of Oncolytic Viruses for Solid Tumors

Mirimus, Inc Partners with St John s Athletics to Enable COVID-19 Surveillance Testing of Student Athletes Using Pioneering SalivaClear Pooled Testing Platform

Share this article Share this article NEW YORK, April 20, 2021 /PRNewswire/ Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced that since November 2020 it has worked with St. John s University, a coeducational Catholic and Vincentian university in New York, to conduct rigorous COVID-19 surveillance testing of student athletes using its pioneering SalivaClear COVID-19 pooled saliva testing platform. The SalivaClear platform consists of three key elements – saliva-based sampling, pooled testing and gold-standard PCR molecular diagnostics – that, when combined, enable frequent, high-quality, high-throughput, low-cost detection of SARS-CoV-2, the virus that causes COVID-19. Mirimus SalivaClear COVID-19 Pool Testing St. John s initiated its COVID-19 surveillance program on June 26, 2020 and tests all 300+ student-athletes participating in the university s athletic program, which includes 17 sports, as well as coaches and staff, at least

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.